Streetbeat News

Analyst Ratings

F

Redburn Atlantic analyst Adrian Yanoshik has initiated coverage on Ford Motor Company (NYSE:F) with a Sell rating and set a price target of $10.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 12:07 pm

NKLA

Baird analyst Ben Kallo has initiated coverage on Nikola Corporation (NASDAQ:NKLA) with an Outperform rating and set a price target of $2 for the stock.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 12:06 pm

WBS

Webster Financial Corporation (NYSE:WBS) reported Q4 earnings per share of $1.46, meeting market estimates, but fell short on sales with $571.02 million against expectations of $602.807 million. Despite the sales miss, the company highlighted strong financial performance and strategic accomplishments, including the acquisition of Ametros Financial. Shares dropped 2.3% after the report. Analysts from Raymond James and JP Morgan raised their price targets for WBS, with Raymond James maintaining an Outperform rating and JP Morgan upgrading the stock from Neutral to Overweight.

Portfolio Pulse from Avi Kapoor

January 24, 2024 | 12:05 pm

ALT

Goldman Sachs analyst Corinne Jenkins has reinstated coverage on Altimmune (NASDAQ:ALT) with a Neutral rating and set a price target of $13.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 12:04 pm

UBER

Gordon Haskett analyst Robert Mollins downgraded Uber Technologies (NYSE:UBER) from Buy to Hold and set a price target of $66. This change reflects a more cautious stance on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 12:01 pm

ACAD

ACADIA Pharmaceuticals (NASDAQ:ACAD) has received 12 analyst ratings in the last three months, with an average 12-month price target of $34.58, up from the previous $30.29. Ratings range from bullish to indifferent, with recent actions including upgrades and initiations of coverage. The company's financial performance shows strong revenue growth and net margin, but challenges in ROA. ACADIA focuses on CNS disorder treatments and seeks to in-license or acquire complementary products.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 12:00 pm

CFB

CrossFirst Bankshares (NASDAQ:CFB) has received mixed analyst ratings over the past three months, with a recent positive shift in the average 12-month price target to $16.75, up 8.06% from the previous target of $15.50. Analysts from Stephens & Co., Raymond James, and Keefe, Bruyette & Woods have provided ratings ranging from 'Equal-Weight' to 'Outperform' with price targets between $16.00 and $18.00. CrossFirst Bankshares has shown positive revenue growth, a high net margin, and strong ROE and ROA, with a conservative debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 12:00 pm

PD

PagerDuty (NYSE:PD) has received mixed analyst ratings over the past three months, with an average 12-month price target of $28.8, down from the previous $31.00. The company's financial performance shows strong revenue growth but below-average profitability and efficiency metrics, with a high debt-to-equity ratio. Analysts have recently adjusted their ratings and price targets, reflecting changes in market dynamics and company performance.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 12:00 pm

AXR

FBK

Insiders at FB Financial Corporation and AMREP Corporation have made notable stock purchases. FB Financial's 10% owner James Ayers bought 2,000 shares at $38.20 each, while AMREP's 10% owner Rainey Lancaster acquired 1,800 shares at $21.82 each. These insider trades suggest confidence in the companies' prospects. However, FB Financial was recently downgraded by Hovde Group analyst Brett Rabatin, and AMREP reported a decline in quarterly sales.

Portfolio Pulse from Avi Kapoor

January 24, 2024 | 11:57 am

BRLT

TD Cowen analyst Oliver Chen has downgraded Brilliant Earth Group (BRLT) from Outperform to Market Perform and reduced the price target from $3.5 to $3.4.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 11:43 am